Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine

By Herlocher M.L.   Ewasyshyn M.   Sambhara S.   Gharaee-Kermani M.   Cho D.   Lai J.   Klein M.   Maassab H.F.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 172-181

Elsevier

Access to resources Recommend Favorite

The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B

By Power U.F.   Plotnicky H.   Blaecke A.   Nguyen T.N.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 168-176

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the Western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection

By Piedra P.A.   Glezen W.P.   Kasel J.A.   Welliver R.C.   Jewel A.M.   Rayford Y.   Hogerman D.A.   Hildreth S.W.   Paradiso P.R.  

Vaccine, Vol. 13, Iss. 12, 1995-08 ,pp. : 1095-1101

Elsevier

Access to resources Recommend Favorite

Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus

By Hsu K.-H.L.   Crowe J.E.   Lubeck M.D.   Davis A.R.   Hung P.P.   Chanock R.M.   Murphy B.R.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 509-515

Elsevier

Access to resources Recommend Favorite

A novel bipolar mode of attachment to aluminium-containing adjuvants by BBG2Na, a recombinant subunit hRSV vaccine

By Dagouassat N.   Robillard V.   Haeuw J.-F.   Plotnicky-Gilquin H.   Power U.F.   Corvaa N.   Nguyen T.   Bonnefoy J.-Y.   Beck A.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4143-4152

Elsevier

Access to resources Recommend Favorite